FilingReader Intelligence

Alphamab Oncology seeks share repurchase, new share issue mandates

May 20, 2025 at 05:04 PM UTCBy FilingReader AI

Alphamab Oncology (HKEX:9966) announced that it will seek shareholder approval for general mandates to repurchase shares and issue new shares, including reselling or transferring treasury shares, at its annual general meeting on June 12, 2025. The proposed share repurchase mandate would allow the company to repurchase up to 10% of its issued shares. The proposed new share issue mandate would authorize the company to issue up to 20% of its issued shares. Shareholders will also vote on the re-election of directors Dr. XU Ting, Mr. CHO Man, and Mr. WEI Kevin Cheng, and the re-appointment of Deloitte Touche Tohmatsu as auditors.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Alphamab Oncology publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →